chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Rapid pulse and elevated heart rate; TIRED; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Rapid pulse and elevated heart rate) and FATIGUE (TIRED) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included ACICLOVIR, VITAMINS NOS, CALCIUM and METOPROLOL for an unknown indication.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, the patient experienced HEART RATE INCREASED (Rapid pulse and elevated heart rate) and FATIGUE (TIRED). On 02-Feb-2021, HEART RATE INCREASED (Rapid pulse and elevated heart rate) had resolved. At the time of the report, FATIGUE (TIRED) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Heart rate: rapid Rapid pulse and elevated heartrate for a while.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included the patient laying down.
Swelling, hard lump at the sight of injection. Bright red circle rash 2 by 3 inches, with a second lighter red circle rash 6 by 6 inches. Itching at sight.
chills; felt horrible; This is a spontaneous report received from contactable reporter(s) (Nurse) from a sales representative.  A male patient in his 50's received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history included: "pneumonia" (unspecified if ongoing), notes: hospitalized in his early 30s with severe pneumonia requiring intubation; "hospitalized" (unspecified if ongoing), notes: in his early 30s; "intubation" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: CHILLS (non-serious), outcome "recovered"; MALAISE (non-serious), outcome "recovered", described as "felt horrible".  Additional information: the patient is male, currently 50+ years old. No underlying medical conditions (UMCs) but was hospitalized in his early 30s with severe pneumonia requiring intubation. The nurse reporter was the patient's wife. The patient received the vaccine at an early morning appointment. He felt fine all day but had chills all night beginning early evening which lasted through the night without any other complaints except felt horrible and was resolved by morning.  The information on the batch/lot number for pneumococcal 20-val conj vac (dipht CRM197 protein) has been requested and will be submitted if and when received.
Pt recvd 2nd dose of Hep B vax 26JUL92 & immed following exp pain @ inject site; later lightheaded as if were drunk; by evening exp fever, malaise, aching joints-went to ER; noted enlarged spleen, LDH 1600 & liver enzymes in 50 to 60 range;
After about 10 min, she noted numbness and tingling in the 4th and 5th digits of the hand on the side where the injection was given. She felt SOB and like she might pass out though admits this may be from anxiety. She remained in the vaccine waiting area for 45 minutes, she notified staff and was provided something to drink. She was eventually dismissed and returned to work where she completed her scheduled shift on Med Surg.  On Friday, she felt numbness and tingling in both hands, both feet, and her face intermittently that persisted into Saturday.  On Sunday she noted swelling in both hands to the point that she could not put her rings on. The numbness and tingling was improved in hands and face but persisted in her feet.  Monday she reported that swelling is improved but still present, and there is still slight tingling in her hands. She also notes that she has been fatigued since receiving the vaccine. She had injection site pain and some generalized muscle achiness for about 36 hours after receiving the vaccine, but that has resolved.  Today (Tuesday) she reports continued sensation of mild swelling in hands, reporting that they feel tight. Otherwise symptoms appear to be resolving.
Patient started 3 days later with itching at injection site and the patient had been to the doctor, which had given him medications. A few days later the irritation became worse and the patient went to the ER. The patient was developing blisters and the ER gave him anti-allergy medication and sent him home. The patient was later hospitalized due increased number of blisters that was multiplying and was covering the torso and neck, and the upper part of his legs including his privates. The final diagnosis of the hospital was bullous pemphigoid.
1 week after shot developed redness/warmth and swelling approximately 6 cm. Mostly better 7/28/14 - only mild swelling.
Patient recieved dose from a vial which was initially stored in the refrigerator 01-Mar-2022 and administered on 30Mar2022 after 30-day Use By Date of expiry 19Mar2022; Patient was vaccinated on 30Mar2022 at 11:03 from vial that was expired on 19Mar2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was vaccinated on 30Mar2022 at 11:03 from vial that was expired on 19Mar2022) and PRODUCT STORAGE ERROR (Patient recieved dose from a vial which was initially stored in the refrigerator 01-Mar-2022 and administered on 30Mar2022 after 30-day Use By Date of expiry 19Mar2022) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013H21B) for COVID-19 vaccination.     Patient don't have any acute illnesses at the time of vaccination and up to one month before and no chronic or long-standing health conditions. It was reported that patient has never been diagnosed or tested positive for COVID-19.  Concurrent medical conditions included Latex allergy.    On 30-Mar-2022 at 11:03 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 30-Mar-2022 at 11:03 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was vaccinated on 30Mar2022 at 11:03 from vial that was expired on 19Mar2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Patient recieved dose from a vial which was initially stored in the refrigerator 01-Mar-2022 and administered on 30Mar2022 after 30-day Use By Date of expiry 19Mar2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was vaccinated on 30Mar2022 at 11:03 from vial that was expired on 19Mar2022) and PRODUCT STORAGE ERROR (Patient recieved dose from a vial which was initially stored in the refrigerator 01-Mar-2022 and administered on 30Mar2022 after 30-day Use By Date of expiry 19Mar2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  The patient didn't seek medical attention. No patients had reported having any adverse events. Vial was initially stored in the refrigerator on 01-Mar-2022. The vial didn't undergo any temperature excursions.  No treatment information was provided by the reporter.
Rash on lower back, waistline, and buttocks approx 24 hrs after injection. Rash lasted approx 1 week.
A rash developed at the injection site on the lateral side of the left arm approximately 4-5 inches in diameter. The rash improved with no treatment.
This is a spontaneous report from a contactable physician (patient). A 65-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EL3247, Expiration date: unknown), via an unspecified route of administration, administered in Arm Left on 22Feb2021 13:30 (age at vaccination: 65-years-old) as dose 1, single for COVID-19 immunization. The patient's medical history included treated hypertension. The patient had no known allergies to medications, food, or other products. The patient did not receive any concomitant medications or other medications in two weeks. The facility where the most recent COVID-19 vaccine was administered was clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 22Feb2021, at 19:00, the patient experienced grade 1 severity soreness at site of vaccination following injection. Improved in severity by next day. No interference with activity, no analgesics required. No treatment was received for the adverse event. The outcome of the event was recovering.  No Follow-up attempts are needed. No further information is expected.
Fever, headache, mild nausea, ache in lower back and muscles, fatigue. Treated with aspirin and acetominophen and rest. Recovered in about 4 days. Also had soreness at injection site for several days, but that is pretty normal for me.
Severe headache, Fever, Nausea, vomiting all day from 6am til 5pm. Still had headache on 12/11/09.
9/15/2022 I had been noticing trouble opening jars and pain in my hands and in my joints. My fine motor movements were harder. It has progressively gotten worse with an achy feeling. I confirmed with a migraine specialist that it is not related to migraines. I have an appointment with my PCP on 12/14/2022.
Developed pruritic papules on both arms and neck the day after 1st Moderna vaccine, developed same bumps the same evening after vaccine #2 , on back, neck and behind left ear. releived by taking Benadryl
Sore arm; The patient received the third/booster dose of BNT162b2.; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FH8028) via an unspecified route of administration in the left arm on 11Nov2021 at 16:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 21Mar2021 at 09:00 (at the age of 29-years-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EU20162) via an unspecified route of administration in the left arm on 15Apr2021 at 09:45 (at the age of 29-years-old), both as a single dose for COVID-19 immunisation. On 12Nov2021 at 05:00, the patient experienced sore arm. The adverse event did not result in doctor or other health care professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm was resolving at the time of this report.
Soreness at and around the injection site on the right upper arm; Coughing; tenderness in the axillary region of the right arm; slight swelling in the axillary region of the right arm; This is a spontaneous report from a contactable healthcare professional (patient herself). A 25-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EJ1686, expiry date not reported), via an unspecified route of administration on the right arm on 31Dec2020 09:15 at single dose for COVID-19 immunization. Medical history included biliary dyskinesia from an unknown date and unknown if ongoing, and cholecystectomy (gallbladder surgically removed Nov2019), irritable bowel syndrome subtype C (diagnosed Jul2020), and COVID-19 on an unspecified date prior vaccination. Concomitant medications included polyethylene glycol [macrogol] and amitriptyline. The patient experienced soreness at and around the injection site on the right upper arm on 01Jan2021 10:00; tenderness in the axillary region of the right arm on Jan2021; slight swelling in the axillary region of the right arm on Jan2021; and coughing on 01Jan2021 10:00. No therapeutic measure was taken as a result of the events. Clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Patient developed dizziness and lightheaded 15 minutes after the vaccine. Then felt fatigued the next day. Patient is an avid runner who runs three to four times week. Today (4/15/21), patient developed tachycardia in the high 180s ten minutes into her run. She then stopped running and started walking on flat surface for 30 minutes in hopes to slow down her heart rate. However, after 30 minutes of walking her heart rate remained in the 185 to 205 beats per minutes. The tachycardia lasted for one hour since she stopped running. She then came to the ED for check ups.
The evening after 2nd dose I had horrible body aches to where I could not walk, fever102, unbearable headache , nausea, profuse sweating. As of now over a week later, my fever is down to 99 but I still experiencing debilitating body aches and fatigue along with uncontrollable sweating. I?m very scared
Pt fainted appr. 5 mins after injection of vaccines. Pt came to and then fainted again after coming too, pt states she was nauseated. Pt sweating & pale.
Severe chills, total body aches, nausea, headache, low grade fever 99.7. Pain at injection site. Lethargic very sleepy
Extraneous IPV vaccine and out of range recommended age range with Pentacel (DtaP+Hib+IPV). Mother notified, no adverse effect/reaction reported.
On 8-9-12 pt had blackout spell while getting GARDASIL. Pt stayed in office for 30 min after shot lying down. BP was WNL.
Sore arm; quarter size hard red reaction; lymph nodes on the same arm got swollen; two quarter size hard red reaction; itching; A spontaneous case report was received from a other healthcare facility staff member concerning a 57 years old female patient was participating in the mRNA-1273 Emergency Use Program and experienced sore arm and a quarter size hard red reaction, then, the lymph nodes on the same arm got swollen and then it got to a two-quarter size. It's red, hot and started itching.   The patient received their first of two planned doses of mRNA-1273 on 08-01=2021 intramuscularly for prophylaxis of COVID-19 infection.  The Lot/Batch no was 026L20A  In a chronological sequence, it started with a sore arm and a quarter size hard red reaction then the lymph nodes on the same arm got swollen on 08-01-2021. Yesterday , it got to a two  quarter size. Its red, hot and started itching.     Treatment for the event was unknown  however Patient is immunocompromised and takes medication for her rheumatoid arthritis and Naproxen daily    Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events were considered to be unknown  Based on agency comment, determined causality missing, please add possible for (Pain in extremity, vaccination site lymphadenopathy and vaccination site induration)
Angioedema; Urticaria; A spontaneous report was received from a physician concerning a 46-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced angioedema and urticaria.   The patient's medical history was not provided.  No relevant concomitant medications were reported.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection.   On an unknown date after receiving the vaccine, the patient experienced angioedema and urticaria.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the events, angioedema and urticaria, was not reported.; Reporter's Comments: This spontaneous report refers to a 46-year-old female patient who experienced unexpected event of angioedema and urticaria a week after administration of the first dose of mRNA-1273, lot # unknown, Exp date-unknown.  There is limited description of the event of angioedema.  However, based on temporal information provided and in the absence of any other etiological factors, a causal association cannot be excluded.
After second vaccination had tachycardia up to 160 beats per minute. Had to go to ER for treatment. Has protracted palpitations since event. Seeing  Cardiologist.
marked Chills/Shivering starting about 8-9 hours after dose (approx. 10:30 pm) lasting until after midnight Fever the next morning at 0500 of 101.9 F Fever of 99 - 100 F and fatigue continued throughout the day;  Managed with Acetaminophen alt/with Ibuprofen Painless Rash at injection site, managed with Loratadine Sore throat for several days managed with the same OTC medications.
Approximately 25min after vaccination, my throat became itchy and my lips were tingly and slightly swollen.  This lasted for hours even after taking Alavert
shingles, loss of hearing, and other zoster-related conditions; other zoster-related conditions; shingles, loss of hearing, and other zoster-related conditions; Information was been received from a lawyer regarding a case in litigation referring to a patient (pt) of unknown age or gender. The pt's concurrent conditions, medical history and concomitant medications were not reported. On 18-SEP-2015, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (dosage regimen, route of administration, anatomical location, lot number and expiration date were not provided) as prescribed and/or administered by a pharmacist for the long-term prevention of shingles and zoster-related conditions. At the time of vaccination, the pt relied on the warning label affixed to zoster vaccine live (ZOSTAVAX), and the information relayed through the pt's healthcare provider(s) that zoster vaccine live (ZOSTAVAX) was an effective in preventing shingles on a permanent basis and did not carry any significant risk of adverse effect, which induced the pt to be vaccinated; and the pt's pharmacist relied on the warning label affixed to zoster vaccine live (ZOSTAVAX) and believed that it was effective in preventing shingles on a long-term or permanent basis, and that it did not carry any significant risks of adverse effects. Subsequent to the inoculation, the pt was treated by a physician for shingles, loss of hearing, and other zoster-related conditions (Ill-defined disorder). As a direct and proximate result of the pt's use of zoster vaccine live (ZOSTAVAX), the pt had and would continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. The outcome of the claimed events was not provided, and causal relationship was reported as related to zoster vaccine live (ZOSTAVAX).
Client had 101 Temp a few days before 09/01/2013 walk in clinic visit, unrelieved by ibuprofen. Walkin clinic told parent to go to Emergency Room temp at this time was 104 degrees. Emergency room did not insert IV or do lab work but they did give ibuprofen and prescribed a antibiotic. Child arrived at E.R. at 5:00pm and was discharged at 1:00 am. Monday 09/02/2013. Client was seen at MD on Tuesday and was told she must of recieved too many vaccines, client was given 7 vaccines on 08/26/2013.
headache; chills; arm ache; aches all over his body; This is a spontaneous report . A contactable consumer (patient's wife) reported that a male patient an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient got aches all over his body, headache and chills, while had an arm ache. The outcome of events was unknown.   Information on the batch number/lot number has been requested
The patient has a history of dementia. She was brought to the ED by EMS on 9/18/23 with a dry cough and increasing weakness that started the day prior. EMS noted the patient lives with her daughter who recently tested positive for COVID. A COVID PCR test performed in the ED resulted positive. The patient was admitted 9/18/23 -9/28/23, with discharge diagnoses including SARs-CoV-2 viral infection, among other diagnoses. Of note, the patient has received the primary COVID vaccine series and two boosters.
Immediate dizziness at the time of injection that lasted about 20 minutes. Extremely painful injection site with swelling (a lump), redness, and heat. Intermittent muscle pain rotating from thigh to calf, to arms, and so on. Slight headache could be muscle in neck. We are applying ice to the injection site.
Flu-like symptoms; This case was reported by a nurse via call center representative and described the occurrence of influenza-like symptoms in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown.   It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not applicable for this report. The age group was not reported, but was selected adult as per vaccine indication. The nurse reported that she had heard that a number of patients reported flu-like symptoms after receiving the 2nd dose of Shingrix
Felt sick after 2nd booster (4th shot) thought it was just normal after vaccine stuff but still felt not great even after a week or two until I ended in the ER in early May 2022. At that time had heart issues and diagnosed with pericardial effusion and enlarged heart etc. started working with pcp and cardiologist to treat and been going down hill ever since with multiple meds to try and help but also developed horrible pain around chest and back and sides of ribs around July. After 4 weeks of suffering not being to sit, lay down, sleep and even day to day functions and after more ER  visits and even more specialist and tests which I?m still seeing/having done it is showing that the last booster pushed my immune system into overdrive where it?s attacking healthy cellls hence the heart and low learning spine leading to possible which I?m still getting more tests. In meantime, the pain is 24/7 I?ve lost quality of life including performing easiest of  tasks and it?s impacting my work too. Prior to this last booster I had no heart issue and no family history and the whole chest and back inflammation and possible arthritis is also something I never experienced or had history. I know my body and everything changed after that last booster that now seems as a healthy person with now really health issues did not need. I only took because my Dr and out public health organizations stated I needed simply due to age. There are obviously other factors that should have been considered yet my quality of life is impacted for ever due to this vaccine.
pt recv vax 16OCT97 & 17OCT97 pt exp significant tenderness & discomfort w/movement @ inj site;